ChiCTR2600118581 版本V1.0 版本创建时间2026/02/09 09:57:32 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600118581 

最近更新日期:

Date of Last Refreshed on:

2026-02-09 09:57:14 

注册时间:

Date of Registration:

2026-02-09 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

中国西部慢性疼痛与心理健康队列研究

Public title:

Cohort Study on Chronic Pain and Mental Health in Western China

注册题目简写:

English Acronym:

研究课题的正式科学名称:

中国西部慢性疼痛与心理健康队列研究

Scientific title:

Cohort Study on Chronic Pain and Mental Health in Western China

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

曾韶婷 

研究负责人:

叶菱 

Applicant:

Shaoting Zeng  

Study leader:

Ling Ye  

申请注册联系人电话:

Applicant telephone:

+86 152 1982 6206

研究负责人电话:

Study leader's
telephone:

+86 189 8060 1894

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

shaoting0403@163.com

研究负责人电子邮件:

Study leader's E-mail:

zerodq_hx@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

四川省成都市国学巷37号

研究负责人通讯地址:

四川省成都市国学巷37号

Applicant address:

No. 37, Guoxue Lane, Chengdu City, Sichuan Province

Study leader's address:

No. 37, Guoxue Lane, Chengdu City, Sichuan Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

四川大学华西医院

Applicant's institution:

West China Hospital of Sichuan University

研究负责人所在单位:

四川大学华西医院

Affiliation of the Leader:

West China Hospital of Sichuan University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2025年审(2409)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

四川大学华西医院生物医学伦理审查委员会

Name of the ethic committee:

Biomedical Ethics Review Committee, West China Hospital of Shichuan University

伦理委员会批准日期:

Date of approved by ethic committee:

2026-01-20 00:00:00

伦理委员会联系人:

邓邵林

Contact Name of the ethic committee:

Shaolin Deng

伦理委员会联系地址:

四川省成都市武侯区国学巷37号八角亭2105

Contact Address of the ethic committee:

Room 2105, Bagjiao Pavilion, No. 37 Guoxue Alley, Wuhou District, Chengdu City, Sichuan Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 28 8542 2654

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

四川大学华西医院

Primary sponsor:

West China Hospital of Sichuan University

研究实施负责(组长)单位地址:

四川省成都市国学巷37号

Primary sponsor's address:

No. 37, Guoxue Lane, Chengdu City, Sichuan Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

四川省

市(区县):

成都市

Country:

China

Province:

Sichuan

City:

Chengdu

单位(医院):

四川大学华西医院

具体地址:

四川省成都市国学巷37号

Institution
hospital:

West China Hospital of Sichuan University

Address:

No. 37, Guoxue Lane, Chengdu City, Sichuan Province

经费或物资来源:

无经费来源

Source(s) of funding:

No funding source

研究疾病:

慢性疼痛  

Target disease:

Chronic Pain

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

建立中国西部多个医疗中心的慢性疼痛专病队列,构建接受微创介入治疗的慢性疼痛人群预后相关的数据库。  

Objectives of Study:

Establish specialized chronic pain cohorts across multiple medical centers in Western China, and build a prognosis-related database for chronic pain populations undergoing minimally invasive interventional therapy.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.年龄≥18岁; 2.入院NRS≥4分; 3.慢性疼痛诊断明确,主要疼痛部位包括但不限于:腰背部、颈肩部、四肢关节或头部等,且疼痛病程超过3个月; 4.计划接受微创介入治疗; 5.自愿参加并签署知情同意书。

Inclusion criteria

1. Age >= 18 years; 2. Hospital admission NRS score >= 4; 3. Clear diagnosis of chronic pain, with primary pain sites including but not limited to: lower back, neck and shoulders, limb joints, or head, and a pain duration exceeding 3 months; 4. Planned to undergo minimally invasive interventional therapy; 5. Voluntary participation and signed informed consent form.

排除标准:

1.癌症相关性疼痛; 2.合并严重心、肺、肝、肾功能不全; 3.存在严重认知障碍、精神分裂症或其他无法配合完成评估的精神疾病史; 4.存在沟通障碍、无可靠联系方式或预计无法完成随访; 5.文盲、学历低于小学无法理解量表; 6.身体残疾等致无法独立完成日常活动。

Exclusion criteria:

1. Cancer-related pain; 2. Severe cardiac, pulmonary, hepatic, or renal insufficiency; 3. Severe cognitive impairment, schizophrenia, or other psychiatric disorders that preclude cooperation with assessments; 4. Communication barriers, lack of reliable contact information, or anticipated inability to complete follow-up; 5. Illiteracy or education level below primary school, preventing comprehension of assessment scales; 6. Physical disabilities that hinder independent performance of daily activities.

研究实施时间:

Study execute time:

From 2025-12-01 00:00:00 To 2032-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-02-10 00:00:00 To 2032-06-30 00:00:00

干预措施:

Interventions:

组别:

慢性疼痛患者

样本量:

10000

Group:

Chronic pain patients

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

四川省 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

四川大学华西医院 

单位级别:

三甲 

Institution
hospital:

West China Hospital of Sichuan University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

四川省 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

四川大学华西天府医院 

单位级别:

三甲 

Institution
hospital:

West China Tianfu Hospital, Sichuan University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

NRS 评分

指标类型:

主要指标

Outcome:

NRS score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生活质量

指标类型:

次要指标

Outcome:

quality of life

Type:

Secondary indicator

测量时间点:

测量方法:

简明疼痛评估量表

Measure time point of outcome:

Measure method:

Brief Pain Inventory

指标中文名:

睡眠质量

指标类型:

次要指标

Outcome:

sleep quality

Type:

Secondary indicator

测量时间点:

测量方法:

匹茨堡睡眠质量指数

Measure time point of outcome:

Measure method:

Pittsburgh Sleep Quality Index

指标中文名:

患者整体印象

指标类型:

次要指标

Outcome:

Overall impression of the patient

Type:

Secondary indicator

测量时间点:

测量方法:

整体变化印象量表

Measure time point of outcome:

Measure method:

PGIC

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2026-02-09 09:57:14